22nd Century Group, Inc.

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Technology
    • Our Tobacco Technology
    • Our Cannabis/Hemp Technology
  • VLN Clinical Studies
    • Published Clinical Studies
    • On-Going Clinical Studies
    • Commentaries & Opinion
  • Products
    • SPECTRUM® Variable Nicotine Research Cigarettes
    • Moonlight®
    • VLN®
  • Investors
    • Overview
    • News
    • Events
    • Stock Data
    • SEC Filings / XBRL
    • Corporate Governance
    • Annual Reports
    • FAQs
  • News
    • Press Releases
  • Contact Us

Press Releases

News

News

  • Press Releases
Nov 09, 2017 4:20pm EST

22nd Century Group Files 2017 Third Quarter Report and Announces Conference Call to Provide Business Update

Nov 02, 2017 9:50am EDT

22nd Century Hires Former Reynolds American Vice President

Oct 19, 2017 9:45am EDT

22nd Century Completes Successful Hemp Field Trials with University of Virginia

Oct 11, 2017 9:55am EDT

22nd Century Group Closes $54 Million Common Stock Only Registered Direct Offering

Oct 09, 2017 6:30am EDT

22nd Century Group Announces $54 Million Common Stock Only Registered Direct Offering

Oct 06, 2017 6:30am EDT

Phase III Study using 22nd Century’s SPECTRUM® Research Cigarettes Demonstrates Immediate Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm

Oct 03, 2017 9:50am EDT

National Conference on “Tobacco Regulatory Science” to Address FDA’s New Comprehensive Plan for Nicotine Regulation

Sep 25, 2017 6:00am EDT

22nd Century Now Free of Restrictive License Agreement with British American Tobacco

Sep 13, 2017 9:55am EDT

22nd Century to Speak at Global Tobacco & Nicotine Forum

Aug 23, 2017 9:50am EDT

22nd Century Technology is a “Game Changer”

RSS
  • Prev
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...28
    Next
    © 2021 22nd Century Group, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap